S&P Futures
3,926.50 +22.75 (+0.58%) Dow Futures
31,615.00 +194.00 (+0.62%) Nasdaq Futures
12,105.75 +65.25 (+0.54%) Russell 2000 Futures
1,782.70 +12.90 (+0.73%) Crude Oil
111.24 +1.67 (+1.52%) Gold
1,823.10 -1.70 (-0.09%)
Organogenesis Holdings Inc. (ORGO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.0000 |
| Open | 5.0000 |
| Bid | 0.0000 x 3200 |
| Ask | 0.0000 x 1800 |
| Day's Range | 4.8800 - 5.0500 |
| 52 Week Range | 4.7350 - 17.5000 |
| Volume | |
| Avg. Volume | 1,058,877 |
| Market Cap | 635.32M |
| Beta (5Y Monthly) | 1.60 |
| PE Ratio (TTM) | 7.66 |
| EPS (TTM) | 0.6420 |
| Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ORGO
Related Research
- Organogenesis Holdings Inc.ORGO: Raising target price to $6.00ORGANOGENESIS HOLDINGS INC has an Investment Rating of HOLD; a target price of $6.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.RatingFair ValueEconomic Moat6 days agoArgus Research
- TipRanks
2 “Strong Buy” Stocks Trading at Rock-Bottom Prices
What to do in today’s market? The last few trading sessions of declining stocks would seem to indicate that the late-May rally we saw has run its course. But that doesn’t mean the opportunities for buy-minded investors are all gone. The recent declines, and the overall downward trend we’ve seen year-to-date, have left many fundamentally sound stocks trading at rock bottom prices. And that may have created an opportunity for investors willing do a bit of bottom fishing. The trick for investors, h
- Simply Wall St.
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested a year ago
Investing in stocks comes with the risk that the share price will fall. And there's no doubt that Organogenesis...
- Motley Fool
Organogenesis Holdings Inc. (ORGO) Q1 2022 Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the first quarter 2022 earnings conference call for Organogenesis Holdings Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including Item 1A risk factors of the Company's most recent annual report. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.
